NCT07520214 2026-04-09
Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma
Beijing Neurosurgical Institute
Phase EARLY_PHASE1 Enrolling by invitation
Clinical Trials
9 trialsNCT07371247 2026-01-27
Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07356466 2026-01-21
FUGES032
Fujian Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07316361 2026-01-07
GYNORYLAQ™
Biogenea Pharmaceuticals Ltd.
Phase EARLY_PHASE1 Enrolling by invitation
NCT07285434 2025-12-16
Microlyvaq™
Biogenea Pharmaceuticals Ltd.
Phase EARLY_PHASE1 Enrolling by invitation
NCT07254104 2025-11-28
Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023848 2025-06-17
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023861 2025-06-17
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023068 2025-06-15
⁶⁸Ga-DPA in the Lung Cancer Diagnosis
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Enrolling by invitation